Favipiravir is used to treat patients with mild to moderate COVID-19 disease.
Favipiravir: Antiviral agents
Favipiravir works by blocking the SARS-CoV-2 virus from multiplying which results in decreased viral load in the body thereby restricting the spread of infection and enhancing the recovery process from short-term, mild upper respiratory infections.